Transforming growth factor-β stimulates urokinase expression in tumor- associated macrophages of the breast

Laboratory Investigation

Volumn 78, Issue 1, 1998, Pages 59-71

  Hildenbrand, Ralf ^a   Jansen, Christian ^a   Wolf, Georg ^a   Böhme, Beatrix ^b   Berger, Stefan ^a   Von Minckwitz, Gunter ^a   Hörlin, Albrecht ^a   Kaufmann, Manfred ^a   Stutte, Hans Jochen ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UROKINASE;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 0031906876     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Andreesen R, Picht J, and Löhr G (1983). Primary cultures of human blood-borne macrophages grown on hydrophobic Teflon membranes. J Immunol Methods 56:295-304.
2. Bassing CH, Yingling JM, Howe DJ, Wong T, He WW, Gustafson ML, Shah P, Donahoe P, and Wong XF (1994). A transforming growth factor beta type I receptor that signals to activate gene expression. Science 263:87-89.
3. Bialojan C and Takai A (1988). Inhibitory effect of a marine-sponge toxin okadaic acid, on protein phosphatases: Specificity and kinetics. Biochem J 256:283-290.
4. Chirgwin JW, Przybyla AE, MacDonald RJ, and Rutter WJ (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
5. Cordell II, Falini B, Erber WN, Gosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, and Mason DY (1984). Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229.
6. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen P, and Skriver L (1985). Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266.
7. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, and Garcia M (1993a). Transforming growth factor β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155:595-605.
8. Falcone DJ, McCaffrey TA, Haimovilz-Friedman A, Vergilio JA, and Nicholson AC (1993b). Macrophage and foam cell release of matrix-bound growth factors: Role of plasminogen activation. J Biol Chem 268:11951-11958.
9. Falcone DJ, McCaffrey TA, Mathew J, Mc Adam K, and Borth W (1995). THP1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor β1 via increased expression of urokinase and urokinase receptor. J Cell Physiol 164:334-343.
10. Falcone DJ, McCaffrey TA, and Vergilio (1991). Stimulation of macrophage urokinase expression by polyanions is protein kinase C dependent, and requires protein and RNA synthesis. J Biol Chem 266:22726-22732.
11. Feinberg AP and Vogelstein B (1983). A technique for radio-labelling DNA restrictions endonuclease fragments to high specific activity. Anal Biochem 132:6-9.
12. Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Bontenbal M, Jänicke F, and Klijn JGM (1992). Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 52:6101-6105.
13. Gilfillan AM, Wiggan GA, and Welton AF (1990). The effects of the protein kinase C inhibitors staurosporine and H7 on the IgE dependent mediator release from RBL2H3 cells. Agents Actions 30:223-234.
14. Gorsch SM, Memoli VA, Stukel TA, Gold IL, and Arrick BA (1992). Immunohistochemical staining for TGF-β growth factor β1 associated with disease progression in human breast cancer. Cancer Res 52:6949-6952.
15. Hamilton JA, Whitty GA, Stanton H, Wojta J, Gallichio M, McGrath K, and Ianches G (1993). Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes. Blood 82:3616-3621.
16. Hanks SK, Quinn AM, and Hunter T (1988). The protein linase family: Conserved features and deduced phylogeny of the catalytic domains Science. 241:42-52.
17. Haystead TAJ, Sim ATR, Carling D, Honnor RC, Tsukitani Y, Cohen P, and Hardie DG (1989). Effects of the tumor promotor okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337:78-81.
18. Hildenbrand R, Dilger I, Hörlin A, and Stutte HJ (1995). Urokinase and macrophages in tumour angiogenesis. Br J Cancer 72:818-823.
19. Holmes WE, Pennica D, Blaber M, Rev MW, Guenzler WA, Steffens GJ, and Hevneker HL (1985). Cloning and expression of the gene for pro-urokinase in Escherichia coli. Biotechology 3:923-929.
20. Ignotz RA and Massagué J (1986). Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345.
21. Johnson WD, Mei B, and Cohn ZA (1977). The seperation, long term cultivation, and maturation of the human monocyte. J Exp Med 146:1613-1626.
22. Kelly PMA, Davison RS, Bliss E, and McGee JOD (1988). Macrophages in human breast disease: A quantitative immunohistochemical study. Br J Cancer 57:174-177.
23. Lewis CE, Leek R, Harris A, and McGee JOD (1995). Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages. J Leukoc Biol 57:747-751.
24. Lynch SE, Colvin RB, and Antoniades HNC (1989). Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 84:640-646.
25. Maniatis T, Frisch ET, and Sanbrook J (1989), editors. Isolation and purification of messenger RNA. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
26. Mantovani A, Bottazzi B, Colotta F, Sozzani S, and Ruco L (1992). The origin and function of tumor-associated macrophages. Immunol Today 13:265-270.
27. Massagué J (1990). The transforming growth factor-β-family. Annu Rev Cell Biol 6:597-641.
28. McCartney-Francis N, Mizel D, Wong H, Wahl L, and Wahl S (1990). TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors. 4:27-35.
29. Müller H (1992), editor. The human mammary carcinoma. Stuttgart, Germany: Gustav Fischer Verlag.
30. Noble PW, Henson PM, Lucas C, Mora-Worms, Carre PC, and Riches DW (1993). Transforming growth factor-beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol 151:979-989.
31. Normann SJ (1985). Macrophage infiltration and tumor progression. Cancer Metastasis Rev 4:277-291.
32. Ossowski L (1988). Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52:321-328.
33. Pierce GF, Tarpley JE, Tanagihara D, Mustoe TA, Fox GM, and Thomason A (1992). Platelet-derived growth factor (BB homodimer), Transforming growth factor-β1, and basic fibroblast growth factor in wound healing: Neovessel and matrix formation and cessation of repair. Am J Pathol 140:1375-1388.
34. Rosemary A, Dearing W, and Dearing SJ (1992). Transforming growth factor β1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer 28:641-644.
35. Rutherford MS, Wittsell A, and Schook LB (1993). Mechanisms generating functionally heterogeneous macrophages: Chaos revisited. J Leukoc Biol 53:602-618.
36. Sato Y, Okamura K, Morimoto A, Hamanaka R, Hamaguchi K, Shimada T, Ono M, Kohno K, Sakata T, and Kuwano M (1993). Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp Cell Res 204: 223-229.
37. Schmitt M, Jänicke F, and Graeff H (1990). Tumor-associated fibrinolysis: The prognostic relevance of plasminogen activators u-PA and t-PA in human breast cancer. Blood Coagul Fibrinolysis 1:695-702.
38. Stopelli MP, Corti A, Soffientini A, Cassani G, Blasi F, and Assoian RK (1985). Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U 937 monocytes. Proc Natl Acad Sci USA 82:4939-4943.
39. Thompson WD, Campbell R, and Evans T (1985). Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J Pathol 145:27-37.
40. Travers MT, Barrett-Lee PJ, and Berger V (1988). Growth factor expression in normal, benigne and malignant breast tissue. Br Med J 296:1621-1624.
41. Van Netten JP, Ashmead BJ, Parker IG, Thornton C, Fletcher D, Cavers P, and Brigden ML (1993). Macrophage-tumor cell associations, a factor in metastasis of breast cancer? J Leukoc Biol 54:360-362.
42. Vassalli JD, Bacccino D, and Belin DA (1985). A cellular binding site for the Mr 55:000 form of the human plasminogen activator urokinase. J Cell Biol 100:86-92.
43. Verde P, Stopelli MP, Galeffi P, Di Nocera P, and Blasi F (1984). Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc Natl Acad Sci USA 81:4727-4733.
44. Wahl SM, Allen JB, Weeks BS, Wong HL, and Klotman PE (1993). Transforming growth factor-beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 90:4577-4581.
45. Yasunaga C, Nakashima Y, and Sueishi K (1989). A role of fibrinolytic activity in angiogenesis: Quantitative assay using in vitro method. Lab Invest 61:698-704.
46. Zuk JA and Walker RA (1987). Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J Pathol 152:275-285